Acta Scientific Medical Sciences (ISSN: 2582-0931)

Research ArticleVolume 5 Issue 4

Activity of Apoptosis Markers in HPV-Associated Cervical Pathologies

Vinogradova OP1*, Orlova EA1, Artemova OI2 and Epifanova OV1

1Branch of FSBEI FPE “Russian Medical Academy of Postgraduate Education” of the Ministry of Healthcare of the Russian Federation, Russia
2Scientific Research Institute of Fundamental and Applied Research "("NIIFiPI") FSBEI HE Penza State University”, Russia

*Corresponding Author: Vinogradova OP, Doctor of Medical Sciences, Professor, Branch of FSBEI FPE “Russian Medical Academy of Postgraduate Education” of the Ministry of Healthcare of the Russian Federation, Russia.

Received: March 02, 2021; Published: May 27, 2021

Citation: Vinogradova OP. “Activity of Apoptosis Markers in HPV-Associated Cervical Pathologies". Acta Scientific Microbiology 5.5 (2021): 116-120.

Abstract

Difficulties in managing patients with cervical intraepithelial neoplasia (CIN) encountered in the work of practicing physicians are determined, firstly, by the lack of uniform treatment and diagnostic measures for cervical precancer and its prevention, and secondly, with insufficient understanding of the processes of human papillomavirus (HPV) -induced squamous intraepithelial lesions, mechanisms of action of anti-HPV drugs and, as a consequence, irrational ways of affecting the cervical tissue. In this regard, it seems relevant to develop and clinically test the use of etiopathogenetic effects on the initiating factors and cofactors of oncogenesis in order to create an optimal-radical effect that allows achieving complete regression of the pathological focus. This will reduce the frequency of neoplastic transformation of the cervix in women of the reproductive period, as well as improve the results of treatment and improve the quality of life of patients.


Keywords: Ectocervical Dysplasia; Caspase-1; Caspase-3; Caspase-9; Apoptosis-resistant Phenotype

Bibliography

  1. GG Avtandilov., et al. “Ploidometric diagnosis of precancerous processes and the cervical cancer by cytological preparations”. Russian Clinical Laboratory Diagnostics 11 (2004): 45-47.
  2. MS Afanasyev., et al. “Viral and bacterial nature of dysplasia and the cervical cancer”. Annals of the Russian Academy of Medical Sciences 6 (2004): 35-40.
  3. GA Bazhuttova and LI Tamarazova. “The possibilities of the cytological method of research during preventive examination of the cervical material”. Russian Clinical Laboratory Diagnostics 10 (2004): 38-40.
  4. LD Belotserkovtseva., et al. “A comparative analysis of different methods of treatment of cervical intraepithelial neoplasia associated with HPV infection”. Obstetrics and Gynecology5 (2015): 55-60.
  5. “A Comprehensive Fight against the Cervical Cancer: Clinical Practice Guide”. Geneva: WHO (2014).
  6. AS Dyatlova., et al. “Molecular markers of caspase-dependent and mitochondrial apoptosis: a role in the development of pathology and in the processes of cell aging”. Advances in Modern Biology2 (2018): 126-137.
  7. ZG Kadagidze and AI Chertkova. “Immunity and Cancer”. Practical Oncology2 (2016): 62-73.
  8. M Bakele., et al. “Localization and functionality of the inflammasome in neutrophils”. The Journal of Biological Chemistry8 (2014): 5320-5329.
  9. EM Creagh. “Caspase crosstalk: integration of apoptotic and innate immune signalling pathways”. Trends in Immunology12 (2014): 631-639.
  10. A Ciavattini., et al. “Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be?”. Archives of Gynecology and Obstetrics 4 (2017): 997-1003.
  11. I Jorgensen and EA. Miao. “Pyroptotic cell death defends against intracellular pathogens”. Immunological Reviews1 (2015): 130-142.
  12. V Kumaresan., et al. “Multifunctional murrel caspase 1, 2, 3, 8 and 9: Conservation, uniqueness and their pathogen-induced expression pattern”. Fish and Shellfish Immunology 49 (2016): 493-504.
  13. LS Massad., et al. “2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors”. ASCCP Consensus Guidelines Conference5 (2013): 1-27.
  14. YT Peng., et al. “Multifaceted role of prohibitin in cell survival and apoptosis”. Apoptosis 9 (2015): 1135-1149.
  15. A Pustavoitau., et al. “Role of senescence marker p16 INK4a measured in peripheral blood T-lymphocytes in predicting length of hospital stay after coronary artery bypass surgery in older adults”. Experimental Gerontology 74 (2016): 29-36.
  16. M Taniguchi., et al. “Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy”. Proceedings of the Japan Academy, Ser. B, Physical and Biological Sciences 7 (2015): 292-304.
  17. MW Teng., et al. “From mice to humans: developments in cancer immunoediting”. Journal of Clinical Investigation 9 (2015): 3338-3346.
  18. M Tranberg., et al. “Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program”. BMC Cancer1 (2016): 835.
  19. I Zehbe., et al. “Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus selfsampling versus Papanicolaou cytology”. BMJ Open10 (2016): 117-154.
  20. ELY Wong., et al. “Evaluation of the impact of human papillomavirus DNA selfsampling on the Uptake of Cervical Cancer Screening”. Cancer Nursing1 (2016): 1-11.
  21. JE Vince and J Silke. “The intersection of cell death and inflammasome activation”. Cellular and Molecular Life Sciences: CMLS 11-12 (2016): 2349-2367.

Copyright: © 2021 Vinogradova OP. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is September 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US